Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Roden

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Journal of Biomedical Science|April 30, 2021
A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventionsSsu-Hsueh Tseng, Brandon Lam, Yu Jui Kung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88Rongcun Yang, Francisco Martinez Murillo, Michael J Delannoy, et al.
Plos One|July 8, 2014
Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV PseudovirionsJoshua W Wang, Subhashini Jagu, Chenguang Wang, et al.
Plos One|September 13, 2011
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cellsRavi K Anchoori, Saeed R Khan, Thanasak Sueblinvong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital TractYun-Yan Sun, Shiwen Peng, Liping Han, et al.
BMC Cancer|May 8, 2020
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signalingRuey-Shyang Soong, Ravi K Anchoori, Richard B S Roden, et al.
Cell & Bioscience|February 27, 2016
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated diseaseShiwen Peng, Jin Qiu, Andrew Yang, et al.
Clinical and Experimental Rheumatology|June 20, 2017
Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic diseaseAmi A Shah, Antony Rosen, Laura K Hummers, et al.
Plos Pathogens|January 15, 2025
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformisMargaret Wong, Hsin-Fang Tu, Ssu-Hsieh Tseng, et al.
Plos One|January 7, 2015
Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancerShiwen Peng, Joshua W Wang, Balasubramanyam Karanam, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Journal of Biomedical Science|April 30, 2021
A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventionsSsu-Hsueh Tseng, Brandon Lam, Yu Jui Kung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88Rongcun Yang, Francisco Martinez Murillo, Michael J Delannoy, et al.
Plos One|July 8, 2014
Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV PseudovirionsJoshua W Wang, Subhashini Jagu, Chenguang Wang, et al.
Plos One|September 13, 2011
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cellsRavi K Anchoori, Saeed R Khan, Thanasak Sueblinvong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital TractYun-Yan Sun, Shiwen Peng, Liping Han, et al.
BMC Cancer|May 8, 2020
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signalingRuey-Shyang Soong, Ravi K Anchoori, Richard B S Roden, et al.
Cell & Bioscience|February 27, 2016
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated diseaseShiwen Peng, Jin Qiu, Andrew Yang, et al.
Clinical and Experimental Rheumatology|June 20, 2017
Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic diseaseAmi A Shah, Antony Rosen, Laura K Hummers, et al.
Plos Pathogens|January 15, 2025
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformisMargaret Wong, Hsin-Fang Tu, Ssu-Hsieh Tseng, et al.
Plos One|January 7, 2015
Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancerShiwen Peng, Joshua W Wang, Balasubramanyam Karanam, et al.
Pageof 18